Talks in this Session:
- Cell-Free Tumor DNA Analysis In Liquid Biopsy Using Ultrasensitive Sequencing
- Clinical Application of Liquid Profiling for Precision Medicine
- Exploiting RNA in Liquid Biopsies for Precision Medicine Purposes
- Liquid Biopsy -- Exosomal microRNA Biomarker Signatures in Clinical Diagnostics
- New Developments in Sample Quality Control - Focus on Cell-free DNA
- Exosome-derived Epigenetic Biomarkers for Saliva Diagnostics
- Sensitive, Easy And Fast Monitoring Of Treatment Efficiency, Resistance Development And Disease Progression Using Open Platform QPCR On Liquid Biopsies From Cancer Patients
| Back to GQ2019 overview page |
|---|
